Levels of High-Sensitivity C-Reactive Protein in Heart Transplant Patients

August 2, 2026 updated by: Yasemin Sezgin, Baskent University

Levels of High-Sensitivity C-Reactive Protein in Heart Transplant Patients With and Without Periodontitis

Inflammation plays a key role in the deterioration of chronic heart transplants. Periodontal disease is not limited to the tooth-supporting structures - it also contributes to systemic inflammation. This study explored whether periodontitis is associated with serum high-sensitivity C-reactive protein (hs-CRP) levels in heart transplant patients.

The study included 33 patients who had undergone heart transplantation at Baskent University Hospital. Clinical periodontal parameters were recorded, and blood samples were collected on the same day to measure serum hs-CRP.

Study Overview

Status

Completed

Intervention / Treatment

Detailed Description

Of the 33 patients, 9 (27.3%) had periodontitis, 4 (12.1%) were periodontally healthy, and 20 (60.6%) had gingivitis. Serum hs-CRP was significantly higher in the periodontitis group than in the healthy and gingivitis groups (P = .006). hs-CRP also correlated positively with probing depth (r = 0.358; P = .041), clinical attachment level (r = 0.352; P = .045), and gingival recession (r = 0.422; P = .014).

Elevated hs-CRP in heart transplant patients was associated with periodontitis, supporting the value of regular periodontal visits after transplant.

Study Type

Observational

Enrollment (Actual)

33

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

11 years to 65 years (Child, Adult, Older Adult)

Accepts Healthy Volunteers

No

Sampling Method

Probability Sample

Study Population

The patients who underwent heart transplant between 2004 and April 2016 at Baskent University Hospital,will be asked to participate in the study during routine outpaient visits at Baskent University Hospital

Description

Inclusion Criteria:

Patients who underwent heart transplant procedures at Baskent University Hospital

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Observational Models: Case-Only
  • Time Perspectives: Cross-Sectional

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
periodontitis
periodontitis patients which were diagnosed based on clinical parameters
only clinical parameters were recorded
Other Names:
  • no intervention was made
gingivitis/healthy
Description: "gingivitis healthy patients which were diagnosed based on clinical parameters
only clinical parameters were recorded
Other Names:
  • no intervention was made

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
hs-CRP levels
Time Frame: Day 1
Serum hs-CRP levels were compared between the groups (periodontitis vs. periodontally healthy vs. gingivitis)
Day 1

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

April 20, 2016

Primary Completion (Actual)

May 20, 2018

Study Completion (Actual)

June 10, 2018

Study Registration Dates

First Submitted

September 13, 2018

First Submitted That Met QC Criteria

September 13, 2018

First Posted (Actual)

September 14, 2018

Study Record Updates

Last Update Posted (Actual)

August 4, 2026

Last Update Submitted That Met QC Criteria

August 2, 2026

Last Verified

August 1, 2026

More Information

Terms related to this study

Other Study ID Numbers

  • BaskentU3
  • approval no. 16/02 (Other Identifier: Baskent University IRB)

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe